Ankle exoskeleton aims to boost mobility in seniors
NCT ID NCT06284525
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase study tested whether an ankle exoskeleton that provides resistance and biofeedback can improve walking in older adults with sarcopenia (age-related muscle loss). Nine participants aged 65–85 completed the trial. Researchers measured changes in walking distance, energy use, and ankle strength. The goal is to see if wearable devices can help older people move more easily.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ankle exoskeleton device with resistance and biofeedback
What this could lead to
If it works, this could point toward a simple wearable device to help older adults walk better and reduce fall risk.
What could go wrong
This is a very small early-phase trial with only 9 participants, so results may not apply to everyone. The device may not provide meaningful benefit over standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOPENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Northern Arizona University
Flagstaff, Arizona, 86011, United States